Imunon (IMNN) News Today $1.03 -0.04 (-3.74%) (As of 09/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period Imunon (NASDAQ:IMNN) Trading 5.6% Higher September 19 at 11:59 PM | americanbankingnews.comUPDATE - IMUNON's Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive ManagementSeptember 9, 2024 | globenewswire.comIMUNON to Host R&D Day on September 18thAugust 28, 2024 | globenewswire.comInsider Buying: Imunon, Inc. (NASDAQ:IMNN) CEO Buys 25,000 Shares of StockAugust 17, 2024 | insidertrades.comIMNN: Positive Results for OVATION 2 Trial Supports Advancing IMNN-001 Into Phase 3 Study…August 15, 2024 | msn.comIMUNON Reports Second Quarter 2024 Financial Results and Provides a Business UpdateAugust 14, 2024 | globenewswire.comIMUNON to Hold Second Quarter 2024 Financial Results and Business Update Conference Call on Wednesday, August 14, 2024August 7, 2024 | globenewswire.comImunon Share Price (IMNN.US)August 4, 2024 | lse.co.ukWhy Imunon (IMNN) Stock Is Down 60% TodayJuly 31, 2024 | msn.comImunon’s shares soar after IL-12 therapy success in Phase II trialJuly 31, 2024 | finance.yahoo.comIMUNON Announces $10 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesJuly 31, 2024 | finance.yahoo.comImunon Shares More Than Double on Ovarian Cancer Study ResultsJuly 31, 2024 | marketwatch.comImunon (NASDAQ:IMNN) Stock Quotes, Forecast and News SummaryJuly 31, 2024 | benzinga.comNano-Cap IMUNON's Lead Candidate Shows Overall Survival Of Around 11 Months In Untreated Ovarian Cancer PatientsJuly 31, 2024 | msn.comImunon, Inc.: IMUNON Announces 11.1 Month Increase in Overall Survival in Patients with Newly Diagnosed, Advanced Ovarian Cancer Treated with IMNN-001July 30, 2024 | finanznachrichten.deDow Jumps 200 Points; Pfizer Earnings Top ViewsJuly 30, 2024 | benzinga.comImunon's Advanced Ovarian Cancer Study Data Shows Survival ImprovementJuly 30, 2024 | marketwatch.comImunon’s stock rockets after ovarian cancer treatment’s positive trial resultsJuly 30, 2024 | msn.comWhy Is Imunon (IMNN) Stock Up 259% Today?July 30, 2024 | investorplace.comIMUNON Announces 11.1 Month Increase in Overall Survival in Patients with Newly Diagnosed, Advanced Ovarian Cancer Treated with IMNN-001July 30, 2024 | globenewswire.comImunon Shares Surge Ahead of Results From Ovarian Cancer Treatment StudyJuly 30, 2024 | marketwatch.comIMUNON to Report Topline Results from the Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian Cancer TomorrowJuly 29, 2024 | globenewswire.comIMUNON Announces Database Lock for Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian CancerJune 24, 2024 | globenewswire.comFirst Participants Vaccinated in IMUNON's IMNN-101 Phase 1 Clinical TrialJune 5, 2024 | globenewswire.comIMNN: Results from OVATION 2 Study in Mid-2024…May 16, 2024 | finance.yahoo.comQ1 2024 Imunon Inc Earnings CallMay 15, 2024 | uk.finance.yahoo.comAbstract on Phase 2 Study with IMUNON’s IMNN-001 Plus Bevacizumab Accepted for Presentation at the American Society of Clinical Oncology Annual MeetingMay 15, 2024 | finance.yahoo.comAbstract on Phase 2 Study with IMUNON's IMNN-001 Plus Bevacizumab Accepted for Presentation at the American Society of Clinical Oncology Annual MeetingMay 15, 2024 | globenewswire.comImunon, Inc. (NASDAQ:IMNN) Q1 2024 Earnings Call TranscriptMay 14, 2024 | msn.comImunon Inc (IMNN) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and ...May 14, 2024 | uk.finance.yahoo.comImunon GAAP EPS of -$0.52 beats by $0.05May 13, 2024 | msn.comIMUNON Announces Site Activation for IMNN-101 Phase 1 Vaccine StudyMay 13, 2024 | globenewswire.comIMUNON Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 13, 2024 | globenewswire.comIMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEOMay 8, 2024 | globenewswire.comIMUNON to Hold First Quarter 2024 Financial Results and Business Update Conference Call on Monday, May 13, 2024May 6, 2024 | globenewswire.comImunon, Inc. (IMNN)April 28, 2024 | finance.yahoo.comIMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101April 18, 2024 | finance.yahoo.comIMUNON's IND Application Cleared to Begin Human Testing of IMNN-101April 18, 2024 | globenewswire.comImunon, Inc.: IMUNON Reports Compliance with Nasdaq Listing RequirementsApril 11, 2024 | finanznachrichten.deIMUNON Reports Compliance with Nasdaq Listing RequirementsApril 11, 2024 | globenewswire.comImunon, Inc. (IMNN) Q4 2023 Earnings Call TranscriptMarch 30, 2024 | seekingalpha.comIMUNON Reports 2023 Financial Results and Provides Business UpdateMarch 28, 2024 | globenewswire.comIMUNON Receives $1.3 Million from Sale of its New Jersey Net Operating LossesMarch 25, 2024 | globenewswire.comIMUNON to Hold 2023 Financial Results and Business Update Conference Call on Thursday, March 28, 2024March 21, 2024 | globenewswire.comImunon, Inc.: IMUNON Announces Leadership ChangeMarch 15, 2024 | finanznachrichten.deIMUNON CEO steps down, Executive Chairman takes helmMarch 14, 2024 | uk.investing.comAnalysts Offer Insights on Healthcare Companies: Imunon (IMNN) and CalciMedica (CALC)March 13, 2024 | markets.businessinsider.comIMUNON Files IND Application to Begin Human Testing of IMNN-101March 13, 2024 | globenewswire.comIMUNON Announces Leadership ChangeMarch 12, 2024 | globenewswire.comIMUNON reports promising vaccine study resultsMarch 2, 2024 | uk.investing.com Get Imunon News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNN and its competitors with MarketBeat's FREE daily newsletter. Email Address The election trade you can't lose (Ad)Politics is an unpredictable game. But no matter what happens in the next few months... There's one thing that can't be stopped by anything: Dividends. Download my Dividend Calendar here IMNN Media Mentions By Week IMNN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMNN News Sentiment▼0.000.49▲Average Medical News Sentiment IMNN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMNN Articles This Week▼11▲IMNN Articles Average Week Get Imunon News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PLUR News Today ACST News Today VVOS News Today MGTX News Today QURE News Today ENTA News Today CDXC News Today SCPH News Today BMEA News Today AMRN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMNN) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHow the US Will Win the Great Lithium RaceChina spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...DealMaker | SponsoredThe Perfect Storm for an EV RevoltWith constant talk about Artifical Intelligence, inflation, and the upcoming election clogging the airwaves......Eagle Publishing | SponsoredTrump’s “Tax Free” Retirement StrategySince 1924 — over one hundred years — the US dollar has lost nearly 18x its value. If you're planning on re...Gold Safe Exchange | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | SponsoredAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt i...InvestorPlace | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imunon, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Imunon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
